I. Arginine

Biomedicine and Pharmacotherapy

Volumn 56, Issue 9, 2002, Pages 439-445

  Tapiero, Haim ^a   Mathe G ^b   Couvreur, P ^a   Tew, K D ^c  

^a UNIV PARIS SUD   (France)

^b HÔPITAL PAUL BROUSSE   (France)

^c FOX CHASE CANCER CENTER   (United States)

Author keywords

Arginine; INOS; Nitric oxide

Indexed keywords

ACETYLCHOLINE; ADENOSINE TRIPHOSPHATE; AGMATINE; AMINOGUANIDINE; ARGINASE; ARGININE; BRADYKININ; CREATINE; CYCLOOXYGENASE 2 INHIBITOR; ENDOTHELIUM DERIVED RELAXING FACTOR; GUANIDINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; ORNITHINE; PEROXYNITRITE; POLYAMINE; PROSTAGLANDIN; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; UREA;

AMINO ACID BLOOD LEVEL; ANGIOGENESIS; ATHEROSCLEROSIS; BACTERIUM; BIRD; BLOOD PRESSURE; BREAST CARCINOMA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CARNIVORA; CATABOLISM; CIGARETTE SMOKING; CLINICAL TRIAL; COLON ADENOMA; CORONARY ARTERY DISEASE; CYTOTOXICITY; DEVELOPMENTAL STAGE; DIETARY INTAKE; DRUG ACTIVITY; ENERGY METABOLISM; HEART MUSCLE ISCHEMIA; HORMONE RELEASE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; IMMUNE RESPONSE; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY VASCULAR RESISTANCE; MACROPHAGE; MAMMAL; MAMMAL CELL; MUSCLE METABOLISM; NERVE; NONHUMAN; NUTRITIONAL STATUS; OXIDATION; PRECURSOR; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN SYNTHESIS; PROTOZOON; REVIEW; TESTIS; TUMOR CELL; TUMOR SUPPRESSOR GENE; ULCERATIVE COLITIS; UREA CYCLE; VASCULAR ENDOTHELIUM; VASODILATATION; ANIMAL; GENERAL ASPECTS OF DISEASE; HEALTH; METABOLISM; PHYSIOLOGY;

ANIMALS; ARGININE; DISEASE; HEALTH; HUMANS;

EID: 0036864639     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0753-3322(02)00284-6     Document Type: Article

References (99)

1. Gordon J.I., Hooper L.V., McNevin M.S., Wong M., Bry L. Epithelial cell growth and differentiation III. Promoting diversity in the intestine: conversations between the microflora, epithelium and diffuse GALT. Am J Physiol. 273:1997;G565-570.
2. Hovgaard L., Brondsted H. Current applications of polysaccharides in colon targeting. Crit Rev Ther Drug Carrier Syst. 13:1996;185-223.
3. Reitzer L.J., Magasanik B. Ammonia assimilation and the biosynthesis of glutamine, glutamate, aspartate, asparagines, L-alanine and D-alanine. Neidhardt F.C., Ingraham J.L., Low K.B., Magasanik B., Schaechter M., Umbarger H.E. Escherichia coliandSlmonella typhimurium. vol. 1:1996;302-320 Blackwell Science, Washington, DC.
4. Metges C.C. Contribution of microbial amino acids to amino acid homeostasis of the host. J Nutr. 130:2000;1857S-1864S.
5. Gaudichon C., Laurent C., Mahé S., Marks L., Tomé D., Krempf M. Rate of [15N]leucine incorporation and determination of nitrogenous fractions from gastro-jejunal secretion in fasting humans. Reprod Nutr Dev. 34:1994;349-359.
6. Hendrickson B.A., Guo J., Laughlin R., Chen Y., Alverdy J.C. Increased type 1 fimbrial expression among commensal Escherichia coli isolates in the murine cecum following catabolic stress. Infect Immun. 67:1999;745-753.
7. Hume I.D. Fermentation in the hindgut of mammals. Mackie R.I., White B.A. Gastrointestinal microbiology. Gastrointestinal ecosystems and fermentations. Microbiologically Series. vol. 1:1996;424-469 Chapman & Hall, New York.
8. Wakabayashi Y., Yamada E., Yoshida T., Takahashi H. Arginine becomes an essential amino acid after massive resection of rat small intestine. J Biol Chem. 269:1995;32667-32671.
9. Wu G., Davis P.K., Flynn N.E., Knabe D.A., Davidson J.T. Endogenous synthesis of arginine plays an important role in maintaining arginine homeostasis in postwening growing pigs. J Nutr. 127:1997;2342-2349.
10. Brunton J.A., Bertlo R.F., Pencharz P.B., Ball R.O. Proline ameliorates arginine deficiency during enteral but not parenteral feeding in neonatal piglets. Am J Physiol. 277:1999;E223-231.
11. El-Khoury A.E., Basile A., Beaumier L., Wang S.Y., Al-Amiri H.A., Selvaraj A., et al. Twenty-four-hour intravenous and oral tracer studies with L-[1-13C]-2-aminoadipic acid and L-[1-13C]lysine as tracers at generous nitrogen and lysine intakes in healthy adults. Am J Clin Nutr. 68:1998;827-839.
12. Young V.R., Borgonha S. Nitrogen and amino acid requirements: the Massachusetts Institute of Technology amino acid requirement pattern. J Nutr. 130:2000;1841S-1849S.
13. Fuller M.F., Reeds P.J. Nitrogen recycling in the gut. Annu Rev Nutr. 18:1998;385-411.
14. Metges C.C., Petzke K.J., El-Khoury A.E., Henneman L., Grant I., Bedri S., et al. Incorporation of urea and ammonia nitrogen into ileal and fecal microbial proteins and plasma free amino acids in normal men and ileostomates. Am J Clin Nutr. 70:1999;1046-1058.
15. Castillo L., Beaumier L., Ajami A.M., Young V.R. Whole body nitric oxide synthesis in healthy men determined from [15N]arginine to [15N]citrulline labelling. Proc Natl Acad Sci USA. 93:1996;11460-11465.
16. Beaumier L., Castillo L., Ajami A.M., Young V.R. Urea cycle intermediate kinetics and nitrate excretion at normal and therapeutic intakes of arginine in humans. Am J Physiol. 269:1995;E884-896.
17. Naismith D.J., Rana S.K., Emery P.W. Metabolism of taurine during reproduction in women. Hum Nutr Clin Nutr. 41:1987;37-45.
18. Tapiero H., Tew K.D. Increased glutathione expression in cells induced by Crassostera gigas extract. Biomed Pharmacother. 50:1996;149-153.
19. Lampidis T.J., Kolonias D., Tapiero H. Effects of Crassostrea gigas extract on cardiac cell function in vitro: anti-arrhythmic activity. Cell Pharmacol. 3:1996;241-246.
20. Tapiero H., Gaté L., Dhalluin S., NguyenBa G., Soupramanien V., Kouyate J., et al. The antioxidant effects of Crassostrea gigas in Human volunteers. In Vivo. 12:1998;305-310.
21. Jacksic T., Wagner D.A., Burke J.F., Young V.R. Proline metabolism in adult male burned patients and healthy control subjects. Am J Clin Nutr. 54:1991;408-413.
22. Vente J.P., Von Meyenfeldt M.F., Van Eijk H.M.H., Van Berlo C.L.H., Gouma D.J., Van der Linden C.J., et al. Plasma-amino-acid profiles in sepsis and stress. Ann Surg. 209:1989;57-62.
23. Werner E.R., Fuchs D., Hausen A., Jaeger H., Reibnegger G., Werner-Felmayer G., et al. Tryptophan degradation in patients infected by human immunodeficiency virus. Biol Chem Hoppe-Seyler. 369:1988;337-340.
24. Laurichesse H., Tauveron I., Gourdon F., Cormerais L., Champredon C., Charrier S., et al. Threonine and methionine are limiting amino acids for protein synthesis in patients with AIDS. J Nutr. 128:1998;1342-1348.
25. Wu G. Intestinal mucosal amino acid catabolism. J Nutr. 128:1998;1249-1252.
26. Walker J.B. Creatine: biosynthesis, regulation and function. Adv Enzymol Relat Area Mol Biol. 50:1979;177-242.
27. Visek W.J. Arginine needs, physiological state and usual diets. A reevaluation. J Nutr. 116:1986;36-46.
28. Lewis B., Langkamp-Henken B. Arginine enhances in vivo immune responses in young, adult and aged mice. J Nutr. 130:2000;1827-1830.
29. Wu G. Synthesis of citrulline and arginine from proline in enterocytes of postnatal pigs. Am J Physiol. 272:1997;G1382-1390.
30. De Jonge W.J., Dingemanse M.A., De Boer P.A., Lamers W.H., Moorman A.F. Arginine-metabolizing enzymes in the developing rats small intestine. Pediatr Res. 43:1998;442-451.
31. Jenkinson C.P., Grody W.W., Cederbaum S.D. Comparative properties of arginases. Comp Biochem Physiol. 114B:1996;107-132.
32. Morris Jr S.M. Regulation of enzymes of urea and arginine synthesis. Annu Rev Nutr. 12:1992;81-101.
33. Takiguchi M., Mori M. Transcriptional regulation of genes for ornithine cycle enzymes. Biochem J. 312:1995;649-659.
34. Gotoh T., Sonoki T., Nagasaki A., Terada K., Takiguchi M., Mori M. Molecular cloning of cDNA for nonhepatic mitochondrial arginase (Arginase II) and comparison of its induction with nitric acid synthase in a murine macrophage cell line. FEBS Lett. 395:1996;119-122.
35. Vockley J.G., Jenkinson C.P., Shukla H., et al. Cloning and characterization of the human type II arginase gene. Genomics. 38:1996;118-123.
36. Morris Jr S.M., Bhamidipati D., Kepka-Lenhart D. Human type II arginase: sequence analysis and tissue specific expression. Gene. 193:1997;157-161.
37. Chanda R., Ganguly A.K. Polyamines in relation to human breast, rectal and squamous cell carcinoma. Cancer Lett. 39:1988;311-318.
38. ω-hydroxy-L-arginine selectively inhibits cell proliferation and induces apoptosis in MDA-MB-468 cells. Cancer Res. 60:2000;3305-3312.
39. Featherston W.R., Rogers Q.R., Freedland R.A. Relative importance of kidney and liver in synthesis of arginine by the rat. Am J Physiol. 224:1973;127-129.
40. Thornton F.J., Schaffer M.R., Barbul A. Wound healing in sepsis and trauma. Shock. 8:1997;391-401.
41. Wu G., Morris Jr S.M. Arginine metabolism: nitric oxide and beyond. Biochem J. 336:1998;1-17.
42. Maxwell A.J., Cooke J.P. Cardiovascular effects of L-arginine. Curr Opin Nephrol Hypertens. 7:1998;63-70.
43. Wu G., Meininger C.J. Arginine nutrition and cardiovascular function. J Nutr. 130:2000;2626-2629.
44. Higashi Y., Oshima T., Ozono R., et al. Effect of L-arginine infusion on systemic and renal hemodynamics in hypertensive patients. Am J Hypertens. 12:1999;8-15.
45. Maxwell A.J., Anderson B., Zapien M.P., Cooke J.P. Endothelial dysfunction in hypercholesterlemia is reversed by a nutritional product designed to enhance nitric oxide activity. Cardiovasc Drugs Ther. 14:2000;309-316.
46. Campisi R., Czernin J., Schoder H., Sayre J.W., Schelbert H.R. L-Arginine normalizes coronary vasomotion in long-term smokers. Circulation. 99:1999;491-497.
47. Hutchinson S.J., Sudhir K., Sievers R.E., et al. Effects of L-arginine on atherogenesis and endothelial dysfunction due to secondary-hand smoke. Hypertension. 34:1999;44-50.
48. Cooke J.P. Is atherosclerosis an arginine deficiency disease. J Investig M. 46:1998;377-380.
49. Kritchevsky D., Tepper S.A., Klurfeld D.M. Dietary protein and atherosclerosis. J Am Oil Chem Soc. 64:1987;1167-1171.
50. Giroux I., Kurowska E.M., Caroll K.K. Role of dietary lysine, methionine and arginine in the regulation of hypercholesterolemia in rabbits. J Nutr Biochem. 10:1999;166-171.
51. Vosatka R.J., Kashyap S., Trifiletti R.R. Arginine deficiency accompanies persistent pulmonary hypertension of the newborn. Biol Neonate. 66:1994;65-70.
52. Morris S.M. Jr. Arginine synthesis, metabolism and transport: regulators of nitric oxide synthesis. Laskin J., Laskin D. Cellular and molecular biology of nitric oxide. 1998;57-85 Marcel Dekker, New York, NY.
53. Stuehr D.J. Structure-function aspects in the nitric oxide synthases. Annu Rev Pharmacol Toxicol. 37:1997;339-359.
54. Wu G., Flynn N.E., Flynn S.P., Jolly C.A., Davis P.K. Dietary protein or arginine deficiency impairs constitutive and inducible nitric oxide synthesis by young rats. J Nutr. 129:1999;1347-1354.
55. Pollock J.S., Forsterman U., Tracey W.R., Nakane M. Nitric oxide synthase isozymes antibodies. Histochem J. 27:1995;738-744.
56. Radomski M.W., Palmer R.M.J., Moncada S. Glucocorticoides inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci USA. 87:1990;5193-5197.
57. Lopez-Jaramillo P., Gonzales M.C., Palmer R.M.J., Moncada S. The crucial role of physiological Ca2+ concentrations in the production of endothelial nitric oxide and the control of vascular tone. Br J Pharmacol. 101:1990;489-493.
58. Ignarro L.J. Biosynthesis and metabolism of endothelium-derived nitric oxide. Annu Rev Pharmacol Toxicol. 30:1990;535-560.
59. Moncada S., Higgs A. The L-arginine nitric oxide pathway. New Engl J M. 329:1993;2002-2012.
60. Seljelid R., Eskeland T. The biology of macrophages: I. General principles and properties. Eur J Haematol. 51:1993;267-275.
61. Seljelid R., Busund L.T. The biology of macrophages II. Inflammation and tumors. Eur J Haematol. 52:1993;1-12.
62. Duerksen Hughes P.J., Gooding L.R. Macrophage-mediated cytotoxicity. Sitkovsky M.V., Henkart P.A. Cytotoxic cells. 1993;439-467 Birkhäuser, Boston.
63. Beasley D., Schwartz J.H., Brenner B.M. Interleukin-1 induces prolonged L-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells. J Clin Invest. 87:1991;602-608.
64. Macmicking J., Xie Q.W., Nathan C. Nitric oxide and macrophage function. Annu Rev Immunol. 15:1997;323-350.
65. Michel T., Feron O. Nitric oxide synthases: which, how and why? J Clin Investig. 100:1997;2146-2152.
66. Lala P.K. Significance of nitric oxide in carcinogenesis, tumor progression and cancer therapy. Cancer Metastasis Rev. 17:1998;1-6.
67. Lorsbach R.B., Murphy W.J., Lowenstein C.J., Snyder S.H., Russel S.W. Expression of the nitric oxide synthase gene in mouse macrophages activated for tumor cell killing: molecular basis for the synergy between interferon-g and lipopolysaccharide. J Biol Chem. 268:1993;1908-1913.
68. Xie K., Fiedler I.J. Therapy of cancer metastasis by activation of the inducible nitric oxide synthase. Cancer Metastasis Rev. 17:1998;55-75.
69. Hibbs Jr J.B., Taintor R.R., Vavrin Z., Raclin E.M. Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem Biophys Res Commun. 157:1988;87-94.
70. Xie Q.W., Nathan C. The high-output nitric oxide pathway: role and regulation. J Leukocyte Biol. 56:1994;576-582.
71. Albina J.E., Reichner J.S. Role of nitric oxide in mediation of macrophage cytotoxicity and apoptosis. Cancer Metastasis Rev. 17:1998;39-53.
72. Auvinen M., Passinen A., Anderson L.C., Hölttä E. Ornithine decarboxylase activity is critical for cell transformation. Nature (Lond). 360:1992;355-358.
73. Davidson N.E., Hahm H.A., McCloskey D.E., Woster P.M., Casero R.A. Jr. Clinical aspects of cell death in breast cancer: the polyamine pathway as a new target for treatment. Endocr Relat Cancer. 6:1999;69-73.
74. Marton L.J., Pegg L.E. Polyamines as targets for therapeutic intervention. Annu Rev Pharmacol Toxicol. 35:1995;55-91.
75. Chang C- I., Liao J.C., Kuo L. Macrophage arginase promotes tumor cell growth and suppresses nitric oxide-mediated tumor cytotoxicity. Cancer Res. 61:2001;1100-1106.
76. Salvemini D., Misko T.P., Masferrer J.L., Seibert K., Currie M.G., Needleman P. Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci USA. 90:1993;7240-7244.
77. Vane J.R., Mitchell J.A., Appleton I., Tomlinson A., Bishop-Bailey D., Croxtall J., et al. Proc Natl Acad Sci USA. 91:1994;2046-2050.
78. Salvemini D., Seibert K., Masferrer J.L., Settle S.L., Misko T.P., Currie M.G., et al. Nitric oxide and the cyclooxygenase pathway. Adv Prostaglandin Thromboxane Leukotriene Res. 23:1995;491-493.
79. Fukumura D., Jain R.K. Role of nitric oxide in angiogenesis and microcirculation in tumors. Cancer Metastasis Rev. 17:1998;77-89.
80. Cahlin C., Gelin J., Delbro D., Lönnroth C., Doi C., Lundholm K. Effects of cyclooxygenase and nitric oxide synthase inhibitors on tumor growth in mouse tumor models with and without cancer cachexia related to prostanoids. Cancer Res. 60:2000;1742-1749.
81. Bing R.J., Miyataka M., Rich K.A., et al. Nitric oxide, prostanoids, cyclooxygenase and angiogenesis in colon and breast cancer. Clin Cancer Res. 7:2001;3385-3392.
82. Huang P.L., Huang Z., Mashimo H., Bloch K.D., et al. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature. 377:1995;239-242.
83. White C.R., Brock T.A., Chang L.Y., et al. Superoxide and peroxynitrite in atherosclerosis. Proc Natl Acad Sci USA. 91:1994;1044-1048.
84. Beckman J.S., Beckman T.W., Chen J., Marshall P.A., Freeman B.A. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA. 87:1990;1620-1624.
85. Tamir S., Burney S., Tannenbaum S. DNA damage by nitric oxide. Chem Res Toxicol. 9:1996;821-827.
86. Szabo C., Oshima H. DNA damage induced by peroxynitrite: subsequent biological effects. Nitric Oxide Biol Chem. 1:1997;373-385.
87. Jaiswal M., LaRusso N., Burgart L., Gores G. Inflammatory cytokines induces DNA damage and inhibit DNA repair in colonic carcinoma cells by a nitric oxide-dependent mechanism. Cancer Res. 60:2000;184-189.
88. Chazotte-Aubert L., Hainaut P., Ohshima H. Nitric oxide nitrates tyrosine residues of tumor suppressor p53 protein in MCF-7 cells. Biochem Biophys Res Commun. 267:2000;609-613.
89. Jenkins D.C., Charles I.G., Thomsen L.L., et al. Roles of nitric oxide in tumor growth. Proc Natl Acad Sci USA. 92:1995;4392-4396.
90. Doi K., Akaike T., Horie H., et al. Excessive production of nitric oxide in rat solid tumor and its implication in rapid tumor growth. Cancer. 77:1996;1598-1604.
91. Hussain S.P., Amstad P., Raja K., et al. Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer-prone chronic inflammatory disease. Cancer Res. 60:2000;3333-3337.
92. Ambs S., Merriam W.G., Bennett W.P., et al. Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression. Cancer Res. 58:1998;334-341.
93. Kojima M., Morisaki T., Tsukahara Y., et al. Nitric acid synthase expression and nitric acid production in human colon carcinoma tissue. J Surg Oncol. 70:1999;222-229.
94. Thomsen L.L., Lawton F.G., Knowles R.G., Beesley J.E., Riveros-Moreno V., Moncada S. Nitric oxide synthase activity in human gynaecological cancer. Cancer Res. 54:1994;1352-1354.
95. Thomsen L.L., Miles D.W., Happerfield L., Bobrow L.G., Knowles R.G., Moncada S. Nitric oxide synthase activity in human breast cancer. Br J Cancer. 72:1995;41-44.
96. Cobbs C.S., Brenmen J.E., Aldape K.D., Bredt D.S., Israel M.A. Expression of nitric oxide synthase in human central nervous system tumors. Cancer Res. 55:1995;727-730.
97. Landino L.M., Crews B.C., Timmons M.D., Morrow J.D., Marnett L.J. Peroxynitrite, the coupling product of nitric oxide and superoxide, activates prostaglandin biosynthesis. Proc Natl Acad Sci. 93:1996;15069-15074.
98. Ahn B., Ohhima H. Suppression of intestinal polyposis in APCMin/+ mice by inhibiting nitric oxide production. Cancer Res. 61:2001;8357-8360.
99. Rao C.V., Indranie C., Simi B., Manning P.T., Connor J.R., Reddy B.S. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor. Cancer Res. 62:2002;165-170.